Royal Bank of Canada, the country's biggest bank, beat quarterly profit expectations, helped by its acquisition of HSBC's ...

People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s ...

If you thought deals were over for the season, think again. Plenty of retailers still have some savings holding on. Check out ...

Wall Street analysts were mostly bullish after the results, with several raising price targets for the stock on the ...

And that spot could well come at the expense of SMU — a team with one fewer loss, just because they earned the right to ...

If you have a new or recent Google Pixel phone, the latest software adds a highly useful feature that lets you see exactly ...

Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...

After releasing their 10th studio album “Stung!” June 21, Australian band Pond took their psychedelic rock energy global with ...

Results from the head-to-head study showed treatment with Zepbound resulted in 47% greater relative weight loss than Wegovy, ...

Eli Lilly said Wednesday that its obesity drug Zepbound spurred more weight loss than Novo Nordisk's Wegovy in a head-to-head ...

Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head ...

(Reuters) - Dollar Tree beat third-quarter sales estimates on Wednesday, as more customers shopped at its discount stores for ...